BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 3073901)

  • 1. Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes.
    Clark A; Wells CA; Buley ID; Cruickshank JK; Vanhegan RI; Matthews DR; Cooper GJ; Holman RR; Turner RC
    Diabetes Res; 1988 Dec; 9(4):151-9. PubMed ID: 3073901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical localisation of caspase-3 in pancreatic islets from type 2 diabetic subjects.
    Tomita T
    Pathology; 2010; 42(5):432-7. PubMed ID: 20632819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic islet amyloid and elevated proinsulin secretion in familial maturity-onset diabetes.
    Clark A; Matthews DR; Naylor BA; Wells CA; Hosker JP; Turner RC
    Diabetes Res; 1987 Feb; 4(2):51-5. PubMed ID: 2884060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked islet amyloid polypeptide-positive amyloid deposition: a possible cause of severely insulin-deficient diabetes mellitus with atrophied exocrine pancreas.
    Sugawara K; Kobayashi T; Nakanishi K; Kajio H; Ohkubo M; Sugimoto T; Murase T; Itoh T; Hara M; Kosaka K
    Pancreas; 1993 May; 8(3):312-5. PubMed ID: 8483872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of pancreatic islet amyloid in patients with end-stage renal failure on dialysis treatment.
    de Koning EJ; Fleming KA; Gray DW; Clark A
    J Pathol; 1995 Feb; 175(2):253-8. PubMed ID: 7738722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher islet amyloid load in men than in women with type 2 diabetes mellitus.
    Zhao HL; Sui Y; Guan J; He L; Lai FM; Zhong DR; Yang D; Baum L; Tong PC; Tomlinson B; Chan JC
    Pancreas; 2008 Oct; 37(3):e68-73. PubMed ID: 18815541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of pancreatic endocrine cells including IAPP-expressing cells in non-diabetic and type 2 diabetic cases.
    Iki K; Pour PM
    J Histochem Cytochem; 2007 Feb; 55(2):111-8. PubMed ID: 16982850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid oligomers in diabetic and nondiabetic human pancreas.
    Zhao HL; Sui Y; Guan J; He L; Gu XM; Wong HK; Baum L; Lai FM; Tong PC; Chan JC
    Transl Res; 2009 Jan; 153(1):24-32. PubMed ID: 19100955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Islet amyloid polypeptide in diabetic and non-diabetic Pima Indians.
    Clark A; Saad MF; Nezzer T; Uren C; Knowler WC; Bennett PH; Turner RC
    Diabetologia; 1990 May; 33(5):285-9. PubMed ID: 2198187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-uniform distribution of islet amyloid in the pancreas of 'maturity-onset' diabetic patients.
    Clark A; Holman RR; Matthews DR; Hockaday TD; Turner RC
    Diabetologia; 1984 Nov; 27(5):527-8. PubMed ID: 6391995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic pathology in non-insulin dependent diabetes (NIDDM).
    Clark A; de Koning EJ; Hattersley AT; Hansen BC; Yajnik CS; Poulton J
    Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S39-47. PubMed ID: 8529518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes mellitus in pancreatic cancer: is it a causal relationship?
    Katsumichi I; Pour PM
    Am J Surg; 2007 Oct; 194(4 Suppl):S71-5. PubMed ID: 17903450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Islet Amyloid in Patients With Diabetes Due to Exocrine Pancreatic Disorders, Type 2 Diabetes, and Nondiabetic Patients.
    Ueberberg S; Nauck MA; Uhl W; Montemurro C; Tannapfel A; Clark A; Meier JJ
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32271378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Morphological changes of islet of Langerhans in an animal model of type 2 diabetes].
    Seiça RM; Martins MJ; Pessa PB; Santos RM; Rosário LM; Suzuki KI; Martins MI
    Acta Med Port; 2003; 16(6):381-8. PubMed ID: 15631848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quantitative estimation of pancreatic islet cells in diabetes mellitus].
    Liu TH
    Zhonghua Yi Xue Za Zhi; 1989 Feb; 69(2):83-5, 8. PubMed ID: 2670104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Islet amyloid, metabolic syndrome, and the natural progressive history of type 2 diabetes mellitus.
    Hayden MR
    JOP; 2002 Sep; 3(5):126-38. PubMed ID: 12221327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-cell mass depletion precedes the onset of hyperglycaemia in the GK rat, a genetic model of non-insulin-dependent diabetes mellitus.
    Movassat J; Saulnier C; Portha B
    Diabete Metab; 1995 Dec; 21(5):365-70. PubMed ID: 8586154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased number of islet-associated macrophages in type 2 diabetes.
    Ehses JA; Perren A; Eppler E; Ribaux P; Pospisilik JA; Maor-Cahn R; Gueripel X; Ellingsgaard H; Schneider MK; Biollaz G; Fontana A; Reinecke M; Homo-Delarche F; Donath MY
    Diabetes; 2007 Sep; 56(9):2356-70. PubMed ID: 17579207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-cell deficit due to increased apoptosis in the human islet amyloid polypeptide transgenic (HIP) rat recapitulates the metabolic defects present in type 2 diabetes.
    Matveyenko AV; Butler PC
    Diabetes; 2006 Jul; 55(7):2106-14. PubMed ID: 16804082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic ganglioneuronal amyloid. Occurrence in diabetic cats with islet amyloidosis.
    O'Brien TD; Johnson KH; Hayden DW
    Am J Pathol; 1985 Jun; 119(3):430-5. PubMed ID: 2409805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.